Ignite Creation Date:
2025-12-26 @ 11:12 AM
Ignite Modification Date:
2026-03-01 @ 11:38 PM
Study NCT ID:
NCT02547428
Status:
COMPLETED
Last Update Posted:
2021-11-11
First Post:
2015-09-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-08-03
Start Date Type:
ACTUAL
Primary Completion Date:
2016-06-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-06-04
Completion Date Type:
ACTUAL
First Submit Date:
2015-09-08
First Submit QC Date:
None
Study First Post Date:
2015-09-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-09-15
Results First Submit QC Date:
None
Results First Post Date:
2021-11-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2019-07-16
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-10-14
Last Update Post Date:
2021-11-11
Last Update Post Date Type:
ACTUAL